Emcure Pharmaceuticals consolidated net profit rises 49.97% in the December 2025 quarter
Sales rise 20.42% to Rs 2363.48 crore
Net profit of Emcure Pharmaceuticals rose 49.97% to Rs 230.54 crore in the quarter ended December 2025 as against Rs 153.72 crore during the previous quarter ended December 2024. Sales rose 20.42% to Rs 2363.48 crore in the quarter ended December 2025 as against Rs 1962.63 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales2363.481962.63 20 OPM %20.8518.07 -PBDT456.62326.73 40 PBT351.94229.92 53 NP230.54153.72 50Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content